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Commentary: The complexities of minimizing risks due to UV exposures For many years, the public health message about solar ultraviolet radiation (UV) focused nearly exclusively on its toxicity. Sunlight was a risk to be avoided. Yet, as has been increasingly emphasized in the scientific literature and lay press, UV is an agent that poses both harms and benefits to health. Solar UV exposure presents established risks to the skin and eyes, as well as initiating the predominant source of vitamin D, with recognized contributions to bone health and other possible health benefits. Understanding both sides of the UV and human health ledger is crucial to developing public health policy that will minimize the net burdens associated with UV. Lucas et al. 1 address the complexities of UV exposure by estimating with a single metric [disability-adjusted life years (DALYs)] both the international burden of disease resulting from actual exposures to UV and the health burdens that would follow if very low world UV exposures were achieved. The comparison is limited to established health risks of UV, principally melanoma, other skin cancers, sunburn and certain types of cataracts, and the established health benefits of vitamin D in preventing rickets, osteoporosis and osteomalacia. In examining the potential trade-off between UV damage and inadequate vitamin D, the study assumes existing patterns of vitamin D exposure from non-UV sources, such as diet (natural and fortified foods) and oral supplementation. Although, readers may question or challenge the myriad assumptions that underlie such an exercise, the study dramatizes how much may be at stake if public health policy addresses the risks of UV without being mindful of its impact on vitamin D status. 4 But the importance of the exercise undertaken by Lucas et al. is to make clear that unless dietary/supplement intake in fact substitutes for some UV exposure, there are potentially substantial risks to markedly reducing UV exposure. What is clear is that the shaping of sun exposure policy should not ignore the major benefits of vitamin D, while at the same time acknowledging that UV is a known carcinogen and responsible for skin cancer and other ill effects.
While Lucas et al. 1 usefully estimate health burdens related to UV on a global basis, it is also important to examine the burdens on subpopulations. Subpopulations may differ in the relative risks presented by UV, and this is also complicated by location of residence and season. For those groups with darker skin and thus lower susceptibility to skin cancer, the global approach may inflate the burden of adverse health outcomes linked to UV. The two leading contributors to health burdens due to UV toxicity as assessed by Lucas et al.
1 are melanoma and sunburn, which constitute about one-half the global UV health burden estimated in this exercise. These two disorders, together with non-melanoma skin cancers, would likely comprise a substantially smaller proportion of the health burden of darker skinned subpopulations. Thus, the trade-off in risks related to UV exposure may vary by group, and such differences should inform policy.
The notion that subpopulations matter in public health sun policy is also brought home by Gilchrest's 3 contention that publicizing the benefits of UV exposure can lead to unintended adverse consequences. She argues that positive messages about UV are likely to have contributed to greater UV exposure among young, fair-skinned individuals who are more likely to have adequate vitamin D levels, with less effect on the status of those with substandard levels, including the institutionalized elderly and those with darker skin. There is legitimate concern that publicizing the benefits of UV-without taking into account the particular needs of subpopulations-could increase the current health burden without substantially ameliorating vitamin D inadequacies.
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